Published on in Vol 7, No 4 (2021): Oct-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/25776, first published .
Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort Study

Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort Study

Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort Study

Journals

  1. Zhuang J, Liu Y, Xu X, Cai Y, Liu M, Chen Z, Yang S, Lin J, Hu Z, Kang M, Lin M, He F. Association between physical activity and health-related quality of life: time to deterioration model analysis in lung adenocarcinoma. Journal of Cancer Survivorship 2023;17(6):1769 View
  2. Deutsch T, Pfob A, Brusniak K, Riedel F, Bauer A, Dijkstra T, Engler T, Brucker S, Hartkopf A, Schneeweiss A, Sidey-Gibbons C, Wallwiener M. Machine learning and patient-reported outcomes for longitudinal monitoring of disease progression in metastatic breast cancer: a multicenter, retrospective analysis. European Journal of Cancer 2023;188:111 View
  3. Tsai C, Yang J, Shaverdian N, Patel J, Shepherd A, Eng J, Guttmann D, Yeh R, Gelblum D, Namakydoust A, Preeshagul I, Modi S, Seidman A, Traina T, Drullinsky P, Flynn J, Zhang Z, Rimner A, Gillespie E, Gomez D, Lee N, Berger M, Robson M, Reis-Filho J, Riaz N, Rudin C, Powell S, Bromberg J, Chen L, Dang C, Das J, Eng J, Girshman J, Gucalp A, Hajj C, Higginson D, Iqbal A, Khan A, LaPlant Q, Mann J, Ng K, Reyngold M, Sanford R, Seidman A, Shah R, Shin J, Sugarman S, Traina T, Tsai C, Wu A, Xu A, Zhi W. Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study. The Lancet 2024;403(10422):171 View
  4. Chen Z, Zhuang J, Liu M, Xu X, Liu Y, Yang S, Xie J, Lin N, Lai F, He F. Longitudinal analysis of quality of life in primary lung cancer patients with chlamydia pneumoniae infection: a time-to-deterioration model. BMC Pulmonary Medicine 2024;24(1) View